-- 獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師的觀點總結如下：BioMarin公佈了2026年第一季業績，營收為7.66億美元（年成長3%），超出市場預期1,400萬美元；但非GAAP每股收益為0.76美元，低於市場預期的1.13美元（年減33%），也低於市場預期的0.91美元。該季度業績受到3,100萬美元NAGLAZYME生產費用和Amicus收購成本的影響。 48億美元的Amicus收購案於4月完成，此次收購將GALAFOLD和POMBILITI + OPFOLDA納入BioMarin的罕見疾病產品組合。管理階層將2026年營收預期上調至38.25億美元至39.25億美元，其中數值代表年增20%。預計2026年將有多項研發管線數據成為利好，包括第二季公佈的ENPP1缺乏症治療藥物BMN 401的3期臨床試驗結果和軟骨發育不全治療藥物VOXZOGO的3期臨床試驗數據，這兩項數據均有望支持2026年下半年的監管申報。我們認為，BMRN預計2026年超過55%的收入將在下半年實現，這將導致每股收益確認在下半年集中體現。鑑於BioMarin擁有20億美元的現金儲備和2.21億美元的第一季營運現金流，我們認為其財務狀況保持著相當大的靈活性。
Related Articles
Research
Research Alert: Duolingo: Strong User Growth Supports Q1 Beat
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:DUOL delivered solid Q1 results with revenue climbing to $292M and EPS of $0.89 versus $0.72 in the prior year, driven by 31% subscription revenue growth to $251M and 15% advertising growth to $21M. Operational efficiency improved notably with adjusted EBITDA advancing 33% to $83.4M (28.6% margin, +140 bps) while free cash flow reached $147.8M. The company's AI-powered content creation capabilities enabled publication of 20,500 course units - nearly triple the 2025 run rate - supporting 21% DAU growth to 56.5M and paid subscriber expansion to 12.5M. Management targets FY bookings of $1.28B (+10.5%), revenue of $1.2B (+16.1%), and adjusted EBITDA of $310M (25.7% margin). We expect continued momentum from AI-driven features and expansion into chess, math, and music, though anticipate gross margin compression from 71.0% to ~69.0% by Q4 as AI capabilities broaden. We believe DUOL's medium-term goal of 100M DAUs by 2028 remains achievable given strong user engagement trends and content innovation capabilities.
$DUOL
Asia
Regis Resources to Acquire Vault Minerals in Merger of Equals
Regis Resources (ASX:RRL) agreed to acquire Vault Minerals (ASX:VAU) in a merger of equals to create a major gold producer with a pro forma market capitalization of about AU$10.7 billion, according to a Tuesday joint filing with the Australian bourse.Under the proposed deal, Vault shareholders will receive 0.6947 shares in Regis for each Vault share owned. Regis shareholders will own about 51% of the merged company and Vault shareholders the remaining 49%, per the filing.The combined company will be listed in Australia and is expected to produce more than 700,000 ounces of gold per year through five operating assets across Western Australia.Regis CEO Jim Beyer will be the CEO of the combined firm, with Anthony Rechichi as its chief financial officer and Michael Holmes as chief operating officer.The merger partners said they see opportunity to realize more than AU$500 million of corporate tax benefits and reduce the combined firm's cost of capital.The deal is subject to certain conditions, including court, regulatory, and Vault shareholder approvals, and carries a break fee of about AU$50.7 million.
$ASX:RRL$ASX:VAU
Asia
Regis Healthcare to Benefit from Higher Govt Spending on Aged Care, Says Jefferies
Regis Healthcare (ASX:REG) is expected to reap benefits from higher government funding into aged care sector, Jefferies said Monday in a note, adding that it is awaiting clarity from the upcoming federal budget announcement this month.The government has announced plans for a AU$3 billion investment in aged care, which includes an increased accommodation supplement.The investment firm assumes that if 40% of Regis' residents received a AU$15 higher daily accommodation supplement, the company could see around a 10% boost in EBITDA per place over 12 months. Regis expects fiscal 2026 underlying EBITDA of around AU$135 million.Jefferies is also confident in the company's fiscal 2027 outlook despite near-full occupancy as Regis continues to expand its portfolio and increase the proportion of residents paying Refundable Accommodation Deposit (RAD). The company reported average occupancy of 95.9% in mature homes in the third quarter.Jefferies maintained a buy rating and increased its price target by 35% to AU$9.
$ASX:REG